Arcadia Biosciences Inc expected to post a loss of 89 cents a share - Earnings Preview

Arcadia Biosciences

18/03/2025 20:07

Arcadia Biosciences Inc RKDA.OQ RKDA.O is expected to show a rise in quarterly revenue when it reports  results on March 20 for the period ending December 31 2024

The Davis California-based  company is expected to report a 2.6% increase in revenue to $1.2 million from $1.17 million a year ago, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for Arcadia Biosciences Inc is for a loss of 89 cents per share.

The one available analyst rating on the shares is "buy".

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Arcadia Biosciences Inc is $12.00​, above​ its last closing price of $3.23. ​​​

This summary was machine generated March 18 at 20:07 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)